Clearer labels needed on drugs containing animal products

Patients with specific dietary restrictions may be unwittingly taking medicines containing animal products, suggests an article published in BMJ today.

Dr Kinesh Patel and Dr Kate Tatham say most medications prescribed in primary care contain animal derived products and it is unclear whether they are suitable for vegetarians.

They call for improved labelling, similar to those on food, to help inform doctors, pharmacists and patients about the content of medicines. And they stress that concerned patients should not stop taking their medication without consulting their doctor first.

Specific dietary preferences regarding animal products in food are common in the general population. Influences such as religion, culture, economic status, environmental concern, food intolerances, and personal preferences all play a part in the foods that people choose to consume.

Yet many patients and doctors are unaware that commonly prescribed drugs contain animal products – and simply reading the list of ingredients will not make it clear whether the product meets the patient's dietary preferences.

Problem ingredients include lactose (often extracted using bovine rennet), gelatine (sourced from cows, pigs and occasionally fish) and magnesium stearate (traditionally sourced from cows, pigs and sheep) although some manufacturers now use vegetarian alternatives.

Last year a campaign to vaccinate children in Scotland against influenza was halted because of concern in the Muslim community about pork gelatine within the vaccine.

Even though the absolute levels of animal products in many medications are likely to be minimal, the authors say doctors need to consider this when prescribing "to avoid non-adherence, which is a major healthcare concern."

To ascertain the scale of the problem, they identified the 100 most commonly prescribed drugs in UK in January 2013. Of these, 73 contained one or more of lactose, gelatine, or magnesium stearate. But they found that information on the origins of the contents was difficult to obtain, unclear, inconsistently reported, and sometimes incorrect.

"Our data suggest that it is likely that patients are unwittingly ingesting medications containing with neither prescriber nor dispenser aware," they write.

They call for improved drug labelling, mirroring those standards advised for food. However, they acknowledge it is unlikely that any labelling standard could address all dietary requirements, "and the ultimate solution would be to eliminate animal derived products where possible from medications."

They point out that lactose is already produced by some manufacturers without using rennet, magnesium stearate can be made chemically without animal ingredients and vegetarian capsules to replace gelatine are already available.

"Although vegetarian friendly ingredients may be more expensive than those produced by traditional processes, the costs would diminish as production expanded and they would limit the exposure of to products they find unacceptable," they conclude.

More information: www.bmj.com/cgi/doi/10.1136/bmj.g401

add to favorites email to friend print save as pdf

Related Stories

The alternative to yogurt

Jan 05, 2014

Researchers at the Universitat Politècnica de València have obtained new products fermented with probiotic bacteria from grains and nuts - what is known as plant-based or vegetable "milks" - which are an ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

5 hours ago

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

5 hours ago

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

6 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

6 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments